Roche to Present Lung and Breast Cancer Data at ESMO 2026
Roche said it will present late-stage trial results at the ESMO 2026 cancer meeting in Madrid, including data on divarasib and giredestrant.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
5 results loaded, newest first. End of these results.
Roche to Present Late-Stage Lung and Breast Cancer Data at ESMO 2026
Genentech to Present Late-Stage Cancer Data at ESMO 2026
Genentech says it will present new data, including two late-breaking abstracts, across lung, breast and other cancers at the ESMO annual meeting in Madrid from October 23 to 27.
Pfizer to present 45 oncology abstracts at ESMO 2026
Pfizer said it will present data from 45 company-sponsored, investigator-sponsored and collaborative research abstracts at the European Society for Medical Oncology congress in Madrid, Spain, on Oct. 23-27, 2026.
BeiGene Reports Q2 2026 Results: Full Earnings Call Transcript
BeiGene (NASDAQ: ONC ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary BeiGene reported strong Q2 2026 financial results with $1.7 billion in t